Term
mech of action for levodopa |
|
Definition
precursor in synthesis of DA
**crosses BBB** |
|
|
Term
effect of food on levodopa |
|
Definition
meals delay absorption and reduces plasma concentration |
|
|
Term
|
Definition
|
|
Term
This inhibits AAD in the periphery |
|
Definition
carbidopa
**does NOT cross BBB** |
|
|
Term
what is the on/off phenomenon |
|
Definition
pts motor state fluctuates with each dose turning them back to the off phase until increase in dose happens, which can dysinesias |
|
|
Term
|
Definition
nausea and vomiting, cardiac issues ( peripheral DA)
confusion and hallucination in elderly
possible production of free radicals |
|
|
Term
this should be discontinued 14 days before giving levodopa |
|
Definition
non-specific MAO inhibitors
**can cause hypertensive crisis** |
|
|
Term
this co-factor in AAD activity must be monitored |
|
Definition
|
|
Term
|
Definition
bromocryptine pergolide pramipexole ropinirole |
|
|
Term
These drugs have selectivity at the D2 receptors |
|
Definition
pramipexole and ropinirole |
|
|
Term
which has longer half life: direct dopa ags or levodopa |
|
Definition
|
|
Term
side effects pramipexole and ropinirole |
|
Definition
somnolence, nausea, hallucinations |
|
|
Term
indication for pramipexole and ropinrole |
|
Definition
used ALONE as initial treatment
especially in younger patients |
|
|
Term
|
Definition
last result due to emetic properties |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
mech of action for COMT inhibs |
|
Definition
block peripheral conversion of levodopa to 3-O methyldopa **INCREASING** levodopa half life |
|
|
Term
comt inhib assoc w/hepatoxicity |
|
Definition
|
|
Term
|
Definition
seleginline and rasagiline |
|
|
Term
mech of action for MAO B inhibs |
|
Definition
neuroprotective properties retards metabolism of DA |
|
|
Term
MAO B inhib that forms amphetamine and meth |
|
Definition
|
|